Outsourced Pharma White Papers
-
Tackling Cell & Gene Therapy Manufacturing Challenges
5/30/2024
Allogeneic therapies are gaining popularity due to diversity, scalability, and affordability. A partner with innovative solutions can help streamline the path from discovery to commercialization.
-
Building Local Biomanufacturing Capacity In South Africa
2/11/2025
Biovac evolved from a vaccine supplier to a biopharmaceutical innovator, providing a blueprint for expanding Africa's vaccine manufacturing capacity. Gain valuable insights from their journey.
-
Mitigating Nitrosamine Risks In Pharmaceuticals
6/25/2024
Nitrosamines can come from a range of sources, including raw materials, manufacturing processes, and even water sources. Detecting them requires sensitive analytical methods.
-
Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends
3/12/2025
Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.
-
Microbial Manufacturing Platform For Non-Platform Proteins
9/26/2024
Discover how CASPON® Technology can revolutionize your recombinant protein manufacturing processes and enhance efficiency.
-
Fc-fusion Cell Line Development: Expression And Analytical Strategies
5/15/2023
Understand high titer expression of Fc-fusion proteins using the Apollo™ X platform coupled with integrated quality assessments, enhancing support through the predicted growth in Fc-fusion clinical applications.
-
2024 Global Biopharma Sustainability Review
9/3/2024
What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?
-
Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies
12/13/2024
Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.
-
Boosting CMC Regulatory Efficiency In Gene Therapy
9/30/2024
Ensure your business stays ahead in today’s complex regulatory environment by implementing robust regulatory affairs strategies that streamline compliance and product approvals.
-
Antibody-Drug Conjugates – Catalysts For Chemistry
5/16/2024
Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.